UBS O'Connor’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-40,000
Closed -$635K 517
2016
Q2
$635K Sell
40,000
-116,595
-74% -$1.74M 0.01% 331
2016
Q1
$2.34M Buy
+156,595
New +$2.46M 0.02% 308
2015
Q3
Sell
-54,212
Closed -$1.25M 810
2015
Q2
$1.25M Buy
54,212
+14,212
+36% +$399K 0.01% 530
2015
Q1
$1.41M Buy
+40,000
New +$1.37M 0.01% 469

Other funds holding OTIC

UBS O'Connor's OTIC Position: Q3 2016 in Review

UBS O'Connor sold out of Otonomy, Inc. (OTIC) in Q3 2016, closing a stake of 40,000 shares — an estimated $635K sold.

UBS O'Connor first reported a position in OTIC in Q1 2015 and held it in 4 quarters. The position peaked at $2.34M in Q1 2016. 85 funds tracked by Wall St. Rank hold OTIC as of Q3 2016.

  • UBS O'Connor reported no remaining Otonomy, Inc. position as of Q3 2016 after selling out during the quarter.
  • UBS O'Connor sold 40,000 Otonomy, Inc. shares in Q3 2016, an estimated $635K.
  • UBS O'Connor first reported a position in Otonomy, Inc. in Q1 2015 and held it in 4 quarters.
  • UBS O'Connor's Otonomy, Inc. position peaked at $2.34M in Q1 2016.
  • 85 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.